Table 3: Echocardiographic parameters in severely obese subjects with type 2 diabetes before and after treatment.

Normal valuesControl groupTreatment group
PrePostPrePost

N13131616
Aortic root (mm)20–3733 ± 435 ± 4*33 ± 433 ± 4
IVS (mm)6–1111 ± 1111 ± 1111 ± 2111 ± 2
PW (mm)6–1110 ± 2110 ± 1111 ± 1110 ± 1*
LA (mm)19–4042 ± 441 ± 542 ± 441 ± 3
RV diastolic (mm)7–2326 ± 426 ± 426 ± 326 ± 3
LV diastolic (mm)35–5753 ± 854 ± 950 ± 451 ± 3
LV systolic (mm)20–3934 ± 9235 ± 10129 ± 4130 ± 4
LV mass (g/m)4M < 163226 ± 742233 ± 612209 ± 533198 ± 462*
W < 121
Ejection fraction (%)>5060 ± 1160 ± 1364 ± 567 ± 4

Mean ± standard deviation; * : pre versus post; : control versus treatment; IVS: Interventricular septum; LA: Left atrium; LV: Left ventricle; PW: Posterior wall; RV: Right ventricle.
1One missing subject.
2Two missing subjects.
3Three missing subject.
4Normal values: <163 g/m for men and <121 g/m for women [24].